BlackRock, Inc. (BLK) 13D/13G Filings for Trevi Therapeutics, Inc. (TRVI)

BlackRock, Inc. 13D and 13G filings for Trevi Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-10-17
6:24 pm
Purchase
2025-09-3013GTREVI THERAPEUTICS INC
TRVI
BlackRock, Inc.
BLK
6,804,338
5.600%
6,804,338increase
(New Position)
Filing